In the DetectedIssue resource for FHIR stu3 , the date attribute identifies the When identified
"date": "2014-01-05"
"status": "final"
"category": {
"coding": [
{
"code": "DRG",
"system": "http://hl7.org/fhir/v3/ActCode",
"display": "Drug Interaction Alert"
}
]
}
"patient":
"severity": "high"
"reference":
"author": {
"reference": "Device/software"
}
"detail": "Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding."
"date": "2014-01-05"
"mitigation": [
{
"action": {
"text": "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring",
"coding": [
{
"code": "13",
"system": "http://hl7.org/fhir/v3/ActCode",
"display": "Stopped Concurrent Therapy"
}
]
},
"date": "2014-01-05",
"author": {
"display": "Dr. Adam Careful",
"reference": "Practitioner/example"
}
}
]
"implicated": [
{
"display": "500 mg Acetaminophen tablet 1/day, PRN since 2010",
"reference": "MedicationStatement/example001"
},
{
"display": "Warfarin 1 MG TAB prescribed Jan. 15, 2015",
"reference": "MedicationRequest/medrx0331"
}
]
"identifier":